Functional effects of increasing omega-3 fatty acid intake.
Carlson
S E
SE
D001095:Arachidonic Acids / Q000378:metabolism; D001827:Body Height / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004042:Dietary Fats, Unsaturated / Q000378:metabolism / Q000627:therapeutic use*; D004281:Docosahexaenoic Acids / Q000097:blood / Q000378:metabolism; D004910:Erythrocyte Membrane / Q000378:metabolism; D015525:Fatty Acids, Omega-3 / Q000378:metabolism / Q000627:therapeutic use*; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006128:Growth / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000378:metabolism / Q000627:therapeutic use*; D008297:Male; D008563:Membrane Lipids / Q000032:analysis / Q000378:metabolism; D010743:Phospholipids / Q000032:analysis / Q000378:metabolism; D017962:alpha-Linolenic Acid / Q000378:metabolism / Q000627:therapeutic use*
D001095:Arachidonic Acids; D004042:Dietary Fats, Unsaturated; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D008041:Linoleic Acids; D008563:Membrane Lipids; D010743:Phospholipids; D017962:alpha-Linolenic Acid; D004281:Docosahexaenoic Acids; D019787:Linoleic Acid